Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Conditions
Interventions
Tradipitant
Placebo
Locations
28
United States
Vanda Investigational Site
Encinitas, California, United States
Vanda Investigational Site
Encino, California, United States
Vanda Investigational Site
Lomita, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
Miami, Florida, United States
Start Date
January 19, 2016
Primary Completion Date
August 4, 2017
Completion Date
August 4, 2017
Last Updated
June 13, 2024
NCT06461897
NCT07262983
NCT06389136
NCT06342713
NCT07223697
NCT07290803
Lead Sponsor
Vanda Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions